I will admit that I am a recent CRMD investor and don't know much about the CELG JUNO merger, but the talk of CELG acquisitions here has me thinking about my much larger biotech investment. One of the biggest issues companies with CAR T-Cell treatment, like JUNO, is CRS, Cytokine Release Syndrome. It is similar to sepsis where the body's own immune system goes into overdrive and ends up attacking it's own organs. With CRS it can be countered with steroid, but that can actually kill the effectiveness of the cancer therapy, something that you don't want with a treatment that may cost North of $500K. CTSO has an EU approved Cytokine filter that has been used safely in over 47,000 human treatments. At $1000 a treatment it seems like a no brainer as a rescue therapy for CRS from CAR T. I don't think CTSO is looking to sell until their pipeline matures, but they also look like a good target for CELG. Or they could become a company the size of CELG 5-10 years down the road.
I actually learned of CRMD from the CTSO board.
To the admins, if you run a strict board about talking about other companies, feel free to delete my post. I am just trying to share because CRMD would never have been on my radar without the post on the CTSO board. Up over 100% in 5 months is a great thing!
Market Data 
Markets 
AI
